Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	183,832	175,818	159,100	-	-	-
Market Cap Growth	10.51%	10.51%	-	-	-	-
Enterprise Value	180,684	173,015	157,079	-	-	-
Last Close Price	1757.20	1680.60	1512.33	-	-	-
PE Ratio	49.47	47.31	51.64	-	-	-
Forward PE	40.60	41.55	43.46	-	-	-
PS Ratio	15.32	14.65	15.65	-	-	-
PB Ratio	10.14	9.70	10.42	-	-	-
P/TBV Ratio	10.15	9.71	10.42	-	-	-
P/FCF Ratio	137.86	131.85	88.50	-	-	-
P/OCF Ratio	75.18	71.90	59.93	-	-	-
PEG Ratio	1.85	1.66	1.43	-	-	-
EV/Sales Ratio	15.06	14.42	15.45	-	-	-
EV/EBITDA Ratio	35.78	34.17	35.81	-	-	-
EV/EBIT Ratio	40.10	38.28	40.61	-	-	-
EV/FCF Ratio	135.50	129.75	87.37	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.09
Debt / EBITDA Ratio	0.01	0.01	0.02	0.09	0.22	0.27
Debt / FCF Ratio	0.02	0.02	0.05	0.31	1.19	-
Asset Turnover	0.64	0.64	0.63	0.60	0.57	0.58
Inventory Turnover	1.87	1.87	1.17	0.94	0.99	0.88
Quick Ratio	4.56	4.56	4.55	2.43	2.71	3.92
Current Ratio	6.17	6.17	6.31	3.79	4.08	5.74
Return on Equity (ROE)	22.26%	22.26%	21.88%	20.06%	16.64%	26.55%
Return on Assets (ROA)	15.13%	15.13%	15.04%	13.26%	11.47%	17.80%
Return on Capital (ROIC)	16.85%	16.85%	16.92%	15.07%	12.70%	19.78%
Return on Capital Employed (ROCE)	24.40%	24.40%	24.80%	22.70%	19.80%	28.10%
Earnings Yield	2.02%	2.11%	1.94%	-	-	-
FCF Yield	0.73%	0.76%	1.13%	-	-	-
Dividend Yield	0.60%	0.64%	0.58%	-	-	-
Payout Ratio	24.63%	24.63%	23.19%	22.31%	40.31%	2.43%
Buyback Yield / Dilution	-0.01%	-0.01%	-	-	-	-
Total Shareholder Return	0.58%	0.63%	0.58%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.